High Relaxivity Contrast Agent for Cardiac MR in Myocardial Scar Assessment
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for High Relaxivity Contrast Agent for Cardiac MR in Myocardial Scar Assessment, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment [Phase 4]